Herbas VPB

Print
EN | LT
LT - COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
EN - COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 35/00
A61K 31/385
A61K 45/06
A61K 39/395
European patent
(11) Number of the document 2227296
(13) Kind of document T
(96) European patent application number 09701364.3
Date of filing the European patent application 2009-01-07
(97) Date of publication of the European application 2010-09-15
(45) Date of publication and mention of the grant of the patent 2015-11-25
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2009/030291
Date 2009-01-07
PCT application publication
(87) Number WO 2009/089260
Date 2009-07-16
Priority applications
(30) Number Date Country code
19778 P 2008-01-08 US
56957 P 2008-05-29 US
Inventors
(72)
JURE-KUNKEL, Maria, US
Grantee
(73) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US
Title
(54) COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
  COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
Last update date 2021-04-30